Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancerWushuang Du, Mingzhou Guo, Shunchang Jiao et al.|Cancer Science|2021Cited by 34
A nomogram‑based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancerLingxiong Wang, Shunchang Jiao, Nijia Chang et al.|Molecular and Clinical Oncology|2021Cited by 23
The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With ChemotherapyLiangliang Wu, Shunchang Jiao, Shengzhi Xie et al.|Frontiers in Immunology|2021Cited by 21
Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transitionChuntao Tian, Shunchang Jiao|Open Life Sciences|2022Cited by 8